Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01661010 · ClinicalTrials.gov registry record
The Clinical Study of Sex Chromosome Variants
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 112
- Enrollment target
NCT01661010: Completed study, sponsored by National Human Genome Research Institute (NHGRI).
NCT01661010 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 112 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01661010 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 112 participants
- Enrollment target
Study Summary
Purpose/Lay Summary: Background: \- Chromosomes are the structures inside of each cell that carry our genetic material (genes). Certain differences in the sex chromosomes are known to cause various diseases, such as infertility, Turner syndrome, or Klinefelter syndrome. However, it is not fully understood why these differences are seen and what clinical findings may be caused with different sex chromosome variants. This study is seeking to learn more about the genetic and clinical characteristics of disorders related to the X and Y chromosomes. Objectives: \- To study related medical conditions in people with sex chromosome variants. Eligibility: * Patients with known sex chromosome differences may be eligible to participate. * Healthy volunteers age 18 - 55 Design: * Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected. * This study will last about 5 days. Participants will have a variety of endocrine and other tests. They will provide blood, urine, and semen samples for these tests. * Imaging studies of the heart and abdomen will be performed. These tests may include ultrasounds and magnetic resonance imaging. * Participants will also have their vision and hearing checked. * Healthy volunteers with have a single day visit for a medical history, physical exam, and blood and skin samples. * Treatment will not be provided as part of this study. * Compensation is offered.
Primary Outcome
To characterize the physical, reproductive, endocrinologic and radiologic phenotype of a group of patients who have known sex-chromosome structural and copy-number variants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2012-07-30 |
What the finished NCT01661010 record still lists
NCT01661010 is an observational study that tracks outcomes without assigning an intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01661010 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01661010 about?
NCT01661010 is a clinical study titled "The Clinical Study of Sex Chromosome Variants". Purpose/Lay Summary: Background: \- Chromosomes are the structures inside of each cell that carry our genetic material (genes). Certain differences in the sex chromosomes are known to cause various diseases, such as infertility, Turner syndrome, or Klinefelter syndrome. However, it is not fully und...
What is the current status of trial NCT01661010?
This trial is currently completed. The enrollment target is 112 participants. The study started on 2012-07-30.
Who is sponsoring clinical trial NCT01661010?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI